On Monday, ARS Pharmaceuticals Inc (NASDAQ: SPRY) opened lower -10.84% from the last session, before settling in for the closing price of $8.21. Price fluctuations for SPRY have ranged from $8.05 to $18.90 over the past 52 weeks.
Company’s average yearly earnings per share was noted -2241.67% at the time writing. With a float of $59.05 million, this company’s outstanding shares have now reached $98.84 million.
ARS Pharmaceuticals Inc (SPRY) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ARS Pharmaceuticals Inc is 40.26%, while institutional ownership is 64.47%. The most recent insider transaction that took place on Nov 13 ’25, was worth 190,050. In this transaction Chief Operating Officer of this company sold 21,828 shares at a rate of $8.71, taking the stock ownership to the 10,789 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Chief Business Officer sold 166,380 for $8.87, making the entire transaction worth $1,476,147. This insider now owns 0 shares in total.
ARS Pharmaceuticals Inc (SPRY) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.51 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.12) by 0.63. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Trading Performance Indicators
Check out the current performance indicators for ARS Pharmaceuticals Inc (SPRY). In the past quarter, the stock posted a quick ratio of 6.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.29 in one year’s time.
Technical Analysis of ARS Pharmaceuticals Inc (SPRY)
ARS Pharmaceuticals Inc (NASDAQ: SPRY) saw its 5-day average volume 2.6 million, a positive change from its year-to-date volume of 1.85 million. As of the previous 9 days, the stock’s Stochastic %D was 8.01%.
During the past 100 days, ARS Pharmaceuticals Inc’s (SPRY) raw stochastic average was set at 0.26%, which indicates a significant decrease from 0.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.74 in the past 14 days, which was higher than the 0.73 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.68, while its 200-day Moving Average is $13.04. Nevertheless, the first resistance level for the watch stands at $7.89 in the near term. At $8.46, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.76. If the price goes on to break the first support level at $7.02, it is likely to go to the next support level at $6.72. Assuming the price breaks the second support level, the third support level stands at $6.15.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Key Stats
There are currently 98,849K shares outstanding in the company with a market cap of 723.57 million. Presently, the company’s annual sales total 89,150 K according to its annual income of 8,000 K. Last quarter, the company’s sales amounted to 15,720 K and its income totaled -44,880 K.
